Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved the Tecnis Symfony® Intraocular Lenses for the treatment of cataracts. The first in a new category of intraocular lenses (IOLs), the Tecnis Symfony lenses are the only lenses in the United States that provide a full range of continuous high-quality vision following cataract surgery, while also mitigating the effects of presbyopia by helping people focus on near objects. The FDA approval includes a version of the lens for people with astigmatism, the Tecnis Symfony Toric IOL.
Cataracts are a common condition, with almost 4 million cataract surgeries performed each year, and that number is expected to increase.1 By age 80, more than half of all Americans either have a cataract or have had cataract surgery.2 However, cataracts do not just impact seniors. In 2016 it is estimated that nearly one in four cataract surgeries will be performed on people younger than 65.1 Many people who have cataracts experience other problems with their vision, such as presbyopia and astigmatism, which the Symfony lenses also address. Presbyopia, which affects most people over age 40, means people have lost the ability to focus on objects up close and often require glasses to perform near visual tasks. Astigmatism is when the cornea is misshapen, which causes blurry or distorted vision.
To view the multimedia release go to:
http://www.multivu.com/players/English/7870151-abbott-intraocular-lenses/
With 830 women dying every day from preventable causes related to pregnancy and childbirth, and over 16,000 children under age five dying daily, Bayer and the White Ribbon Alliance today released critical policy recommendations and launched community programs to support the reduction and prevention of maternal, newborn and child mortality in two developing countries.1,2
Established through a three-year $1.3 million commitment from Bayer, these programs will expand work conducted by White Ribbon Alliance in Bangladesh and Zimbabwe to support the United Nations Secretary General’s Every Woman Every Child movement.
This announcement comes at the one-year anniversary of the Bayer/White Ribbon Alliance commitment in support of the Every Woman Every Child movement and will contribute to the success of the Sustainable Development Goals.
To view the multimedia release go to:
http://www.multivu.com/players/English/77126510-bayer-white-ribbon-alliance-self-care/
An estimated 48 million people in the United States have hearing loss, yet only 20 percent of people who could benefit from a hearing aid wear one. Cost is a major barrier as the average price of a hearing aid is $1,500 per ear, and can run as high as $3,000-$5,000 each. With the introduction of HearTEK™ Leasing from EPIC Hearing Healthcare (EPIC), individuals with hearing loss now have access to the latest name brand hearing aid technology without the barrier of huge upfront costs and with the peace of mind that they will not be locked into out-of-date technology.
“Consumers have gotten used to many of the benefits of leasing their smartphones – no one wants to pay upfront for technology that could be quickly outdated as hearing aid manufacturers regularly introduce new devices with updated features,” said Brad Volkmer, president and CEO, EPIC Hearing Healthcare. “The HearTEK Leasing program is an affordable new way to give more people with hearing loss access to quality hearing aid technology, so they can start hearing life to the fullest.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7808551-epic-heartek-leasing-hearing-aid/
Soy consumption is up 14 percent since 2011,26 yet confusion lingers over soy’s role in everything from human health to food production. To clear up misperceptions, the United Soybean Board (USB) busts five common soy myths with science-backed facts on SoyConnection.com/soy-wisdom.
1) Eating soy does not increase breast cancer risk.
Clinical studies show soy isoflavone exposure does not adversely affect breast tissue as assessed by markers of breast cancer risk, such as breast cell proliferation.1–7 The American Institute for Cancer Research and the American Cancer Society say that women who have been diagnosed with breast cancer can safely consume soyfoods. In fact, the World Cancer Research Fund International has identified a link between soy consumption and an improved survival of breast cancer patients.8-9
“Not only does evidence indicate soyfoods may benefit women with breast cancer, but consuming soy when young helps prevent the onset of this disease later in life27-30,” stated Mark Messina, Ph.D., who has dedicated the past 30 years to understanding the health effects of soyfoods.
To view the multimedia release go to:
http://www.multivu.com/players/English/7877951-united-soybean-board-top-soy-myths/
Feeding America, the nation's largest hunger-relief organization, has partnered with the Ad Council and McCann New York to launch new public service advertisements (PSAs) designed to raise awareness about child hunger in the United States. Featuring the voice of celebrity activist Julianne Moore, who volunteered her time and talent, the PSAs call upon Americans to help children facing hunger in America by supporting the Feeding America nationwide network of food banks.
To view the multimedia release go to:
http://www.multivu.com/players/English/7909951-feeding-america-ad-council-julianne-moore/
Sickle cell disease (SCD) is an inherited, lifelong chronic disorder affecting nearly 100,000 Americans and a growing global health problem that will touch nearly 30 percent more people globally in the next three decades. Though new approaches to managing SCD have led to improvements in diagnosis and supportive care, people living with the disease still have severe complications to overcome. Many are unable to access quality care and are limited by a lack of effective treatment options.
In an effort to identify unmet medical needs for people with SCD, the American Society of Hematology (ASH), along with other groups, issued the State of Sickle Cell Disease: 2016 Report, evaluating the disease in four priority areas — access to care, training and professional education, research and clinical trials, and global health. The report shows that significant improvements are needed across all areas and that, though patients are living longer, the system of care needs to change to ensure a better quality of life. To address these challenges, ASH launched the Sickle Cell Disease Coalition along with more than 20 other organizations who are issuing a call to action that will amplify the voice of the SCD community, promote SCD awareness, and transform SCD care both in the United States and around the globe.
To view the multimedia release go to:
http://www.multivu.com/players/English/7903251-american-society-hematology-sickle-cell-coalition/
Progresso is now using only 100 percent antibiotic and hormone free chicken breasts in all of its 36 chicken soup varieties. Currently available on store shelves nationwide, Progresso is the first large retail soup brand in the United States to have antibiotic and hormone free chicken breasts in its soups.
For decades, Progresso has been committed to continuously improving the quality of its soups. Not only is Progresso now using only white breast meat chicken with no antibiotics or hormones, but the brand is also free from artificial flavors and has removed artificial colors from 60 percent of its soups, with a goal to remove 100 percent by 2019. In addition, the soup brand has reduced sodium levels in more than 40 soup varieties, added seven soups to its certified Gluten Free product line and is increasing its vegetarian soup options.
To view the multimedia release go to:
http://www.multivu.com/players/English/7885251-progresso-antibiotic-free-chicken/
The Ad Council’s I Am A Witness campaign is bringing together the top digital companies in the teen space for the second iteration of the award-winning and unprecedented effort aimed at transforming the “silent majority” of kids who witness bullying each day from passive bystanders into a united, empowered and active collective against bullying. The campaign is the first to create an anti-bullying emoji adopted by Unicode and natively available on nearly all smartphones across the world. There will be activations throughout the month of October to coincide with Bullying Prevention Month.
To view the multimedia release go to:
http://www.multivu.com/players/English/7933951-ad-council-i-am-a-witness-anti-bullying/
Tommy John, the premium men's underwear company, today announced a product line with the NFL's Dallas Cowboys that will see Cowboys branding featured on Tommy John underwear.
As a part of the partnership, Tommy John launched Dallas Cowboys men's underwear that is being sold in the pro shops at AT&T Stadium, the home of the Dallas Cowboys, select Dallas Cowboys Pro Shops, Fans United stores, online at www.tommyjohn.com/cowboys, as well as shop.dallascowboys.com. Tommy John's Cool Cotton and Second Skin Trunks and Boxer Briefs will be emblazoned with the famous Cowboys Star allowing fans to show their support for their favorite team, while being supported by premium underwear. In addition, Tommy John will be exposed to millions of devoted Cowboys fans through Cowboys digital and radio platforms as part of the partnership.
To view the multimedia release go to:
http://www.multivu.com/players/English/7648931-tommy-john-the-big-adjustment/
Ascensia Diabetes Care today announced the availability of the CONTOUR®NEXT ONE blood glucose monitoring system (BGMS) in the United Kingdom, one of the next steps in the evolution of self-monitoring of blood glucose. As part of the system, the CONTOUR®NEXT ONE meter and CONTOUR®DIABETES app seamlessly connect, which makes capturing blood glucose results effortless for people with diabetes. The system enables patterns and trends to be revealed that can help people understand their diabetes, and may help to improve diabetes management.
The system features an easy-to-use wireless-enabled smart meter that links to a smart mobile device via Bluetooth® connectivity. The CONTOUR®NEXT ONE meter gives immediate feedback and also seamlessly connects to the CONTOUR®DIABETES app, which collects, stores and analyses patient blood glucose results received from the meter. The app combines these results with other data recorded by the user, to provide detailed information about their condition that can help them understand how their everyday lives may impact their blood glucose readings, including alerts for critical high or critical low readings. Through the app, meter users can also share with their healthcare professional the reports of their blood glucose results and patterns, either in advance or on the day of their appointment, helping to create more informed discussions.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7954951-contour-next-one-bgms-ascensia/
Napa Valley’s largest independent resort, The Meritage Resort and Spa receives the Platinum Choice Award by Smart Meetings, the meeting industry’s premier resource for meeting professionals. The award recognizes the property for its exemplary standards of excellence in ambiance, amenities, breadth of resources, facility quality, guest services, meeting space and packages, dining options, recreational activities and technical support. Votes were cast by industry professionals, the Smart Meetings editorial team and its readers.
“We are honored to be named one of the best hotels and resorts for meetings and special events in the United States, Canada, Mexico and the Caribbean,” said Sheri Thomas, director of sales and marketing for The Meritage Resort and Spa. “As the largest independent hotel or resort in Napa, Sonoma and Marin counties, we continually strive to provide top quality service and amenities to each of our guests and groups. This award reinforces our commitment to excellence and is a true testament to our team members’ dedication to ensuring that no detail goes unmissed.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7583051-meritage-resort-spa-smart-meetings-award/
CoStar Group, Inc. (NASDAQ: CSGP) has selected Richmond, Virginia for its research operations headquarters, following a national search. As a result, CoStar expects to create approximately 730 jobs in Richmond and invest a quarter billion dollars into the local economy.
CoStar Group creates and delivers the information, marketing, and analytic tools that facilitate the vast majority of commercial real estate transactions in the United States. The CoStar research team curates and certifies information on approximately $1 trillion of potential real estate transactions and tracks billions of dollars of completed deals.
To view the multimedia release go to:
http://www.multivu.com/players/English/7963151-costar-group-selects-richmond-for-research-operations-headquarters/
